Cerora sells “Neuro Diagnostics as a Service” brain health information to aid in the diagnosis of concussion and Alzheimer’s disease; both subjective diagnosis with enormous unmet medical need. For the pharma industry, Cerora is presently selling CNS compound monitoring services for target engagement, dose selection, etc towards companion diagnostics. Customers include physicians, certified athletic trainers, providers and patients as consumers.